Back to results
US 10,209,261 B2Granted
Method for assessing protein identity and stability
AssigneeArmo Biosciences, Inc.
InventorsJohn Brian Mumm, Peter Van Vlasselaer
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods and other technologies that may be used to determine whether compositions (e.g., pharmaceutical compositions) comprising interleukin-10 molecules (e.g., pegylated interleukin-10) meet particular product-related specifications prior to being administered to a subject for the treatment and/or prevention of the diseases, disorders and conditions, and/or the symptoms thereof, described herein.
Claims13
A method of confirming the amino acid sequence of a pegylated interleukin-10 (PEG-IL-10), comprising the steps of:
- a) fragmenting a test PEG-IL-10 with a glutamyl endopeptidase (Endo Glu-C), to yield a test plurality of peptides;
- b) adding a reducing agent in an amount sufficient to reduce the disulfide bonds of the test PEG-IL10;
- (c) separating peptide members of the test plurality of peptides by chromatography;
- (d) analyzing said separated peptide members using ultraviolet absorption spectroscopy to provide a test PEG-IL-10 chromatogram;
- and
- (e) comparing the test PEG-IL-10 chromatogram to a reference standard chromatogram, said reference standard chromatogram generated by Endo Glu-C digestion of a reference standard PEG-IL-10, adding a reducing agent in an amount sufficient to reduce the disulfide bonds of the reference standard PEG-IL-10, separating peptide members of the reference standard PEG-IL-10 by chromatography, and analyzing said separated peptide members using ultraviolet absorption spectroscopy to provide the reference standard PEG-IL10 chromatogram;
- wherein the amino acid sequence of the test PEG-IL-10 is confirmed by the substantial equivalency of the retention time of the peaks of the test PEG-IL-10 chromatogram and the reference standard PEG-IL10 chromatogram.
4 more elements
Dependencies are inferred from the claim text.